Patents by Inventor Jian Ni

Jian Ni has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11438637
    Abstract: Disclosed are systems and methods for improving interactions with and between computers in content generating, searching, hosting and/or providing systems supported by or configured with personal computing devices, servers and/or platforms. The systems interact to identify and retrieve data within or across platforms, which can be used to improve the quality of data used in processing interactions between or among processors in such systems. The disclosed systems and methods automatically analyze a live streaming media file, and identify portions of the media that are highlights. The content classified as a highlight can be shared across social media platforms, and indexed for searching respective to attributes of the video content. The streaming and highlight media content is renderable in a novel, modified video player that enables variable playback speeds for how content is classified, and enables on-demand selections of specific content portions and adjustable rendering displays during streaming.
    Type: Grant
    Filed: May 13, 2020
    Date of Patent: September 6, 2022
    Assignee: YAHOO ASSETS LLC
    Inventors: Bin Ni, Kirk Lieb, Rick Hawes, Yale Song, Benoit Schillings, Vahe Oughourlian, Jordi Vallmitjana, Jennelle Nystrom, Hardik Ruparel, Michael Chen, Adam Mathes, Arunkumar Balasubramanian, Jian Zhou, Matt Edelman
  • Publication number: 20220273965
    Abstract: The present disclosure generally relates to a multi-leaf collimator. The multi-leaf collimator may include a set of leaves installed in a cavity, each leaf of the set of leaves having a length along a first direction. At least a portion of the set of leaves may extend beyond the cavity along the first direction. The set of leaves may be arranged along a second direction, the second direction being different from the first direction. A length of a target leaf of the set of leaves may be less than a length of a reference leaf of the set of leaves. The target leaf may be located in an end portion of the set of leaves along the second direction. The length of the set of leaves may conform to the shape of a maximum therapeutic radiation field.
    Type: Application
    Filed: May 16, 2022
    Publication date: September 1, 2022
    Applicant: SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD.
    Inventors: Jian LIU, Kun YANG, Jian ZHANG, Yanfang LIU, Cheng NI
  • Publication number: 20220251229
    Abstract: This disclosure relates to anti-TNFRSF9 (tumor necrosis factor receptor superfamily member 9) antibodies, antigen-binding fragments, and the uses thereof.
    Type: Application
    Filed: February 22, 2022
    Publication date: August 11, 2022
    Inventors: Yi Yang, Jingshu Xie, Chunyan Dong, Fang Yang, Chengyuan Lu, Yuelei Shen, Jian Ni, Yanan Guo, Yunyun Chen
  • Patent number: 11395928
    Abstract: A system and method for image-guided radiotherapy are provided. The system may include a treatment assembly and an imaging assembly. The treatment assembly may include a first radiation source configured to deliver a treatment beam. The treatment assembly may have a treatment region relating to an object. The imaging assembly may include a second radiation source and a radiation detector. The second radiation source may be configured to deliver an imaging beam, and the radiation detector may be configured to detect at least a portion of the imaging beam. The imaging assembly may have an imaging region relating to the object. The first radiation source may be rotatable in a first plane, and the second radiation source may be rotatable in a second plane different from the first plane, such that the treatment region and the imaging region at least partially overlap.
    Type: Grant
    Filed: December 29, 2018
    Date of Patent: July 26, 2022
    Assignee: SHANGHAI UNITED IMAGING HEALTHCARE CO. LTD.
    Inventors: Jian Liu, Yuelin Shao, Xiao Fang, Cheng Ni
  • Patent number: 11394389
    Abstract: The present disclosure provides a buffer circuit and a buffer. The buffer circuit includes: an input follower circuit for following the voltage change of the first input signal; an input follower linearity boosting circuit for improving follower linearity of the input follower circuit; a first voltage bootstrap circuit for bootstrapping the voltage of the first input signal; a second voltage bootstrap circuit for bootstrapping the voltage of the second input signal; a third voltage bootstrap circuit for providing corresponding quiescent operation point voltage; a compensation follower circuit for following the compensation voltage; a compensation follower linearity boosting circuit for improving follower linearity of the compensation follower circuit; a first load for collecting the buffered voltage; a bias circuit for providing a bias current for the buffer; a bias linearity boosting circuit for improving linearity of the bias circuit; a second load for generating a nonlinear compensation current.
    Type: Grant
    Filed: December 13, 2018
    Date of Patent: July 19, 2022
    Assignee: NO.24 RESEARCH INSTITUTE OF CHINA ELECTRONICS TECHNOLOGY GROUP CORPORATION
    Inventors: Ting Li, Gangyi Hu, Ruzhang Li, Yong Zhang, Zhengbo Huang, Yabo Ni, Xingfa Huang, Jian'an Wang, Guangbing Chen, Dongbing Fu, Jun Yuan, Zicheng Xu
  • Publication number: 20220224320
    Abstract: The present disclosure provides a substrate-enhanced comparator and electronic device, the comparator including: a cross-coupled latch, for connecting input signals to the gate of a cross-coupled MOS transistor to form a first input of the latch; output buffers, connected to the cross-coupled latch for amplifying output signals of the latch; AC couplers, connected to the output buffers for receiving and amplifying the output signals of the latch, coupling the output signals to substrates of the cross-coupled MOS transistors to form second inputs of the latch. The cross-coupled latch is also for output signal regenerative latching based on input signals sampled at the first inputs and input signals sampled at the second inputs. The present disclosure introduces additional substrate inputs to the cross-coupled structure of the conventional latch as the second inputs of the latch.
    Type: Application
    Filed: January 7, 2020
    Publication date: July 14, 2022
    Applicants: NO.24 RESEARCH INSTITUTE OF CHINA ELECTRONICS TECHNOLOGY GROUP CORPORATION, Chongqing GigaChip Technology Co., Ltd.
    Inventors: Ting LI, Zhengbo HUANG, Yong ZHANG, Yabo NI, Jian'an WANG, Guangbing CHEN, Dongbing FU, Zicheng XU
  • Patent number: 11373041
    Abstract: A processor may receive a text segment. The processor may analyze the text segment at a plurality of granularity levels wherein each of the plurality of granularity levels has a comparative selection value for identifying one or more objects of interest within the text segment. The processor may select an optimized granularity level with an optimum comparative selection value. The processor may identify the one or more objects of interest within the text segment. The processor may display the one or more objects of interest to a user.
    Type: Grant
    Filed: September 18, 2020
    Date of Patent: June 28, 2022
    Assignee: International Business Machines Corporation
    Inventors: Jian Ni, Radu Florian, Salim Roukos, Vittorio Castelli
  • Patent number: 11352429
    Abstract: This disclosure relates to anti-PD-1 (Programmed Cell Death Protein 1) antibodies, antigen-binding fragments, and the uses thereof.
    Type: Grant
    Filed: May 19, 2021
    Date of Patent: June 7, 2022
    Assignee: Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
    Inventors: Yi Yang, Chunyan Dong, Fang Yang, Chengyuan Lu, Yuelei Shen, Jian Ni, Yanan Guo, Yunyun Chen, Jingshu Xie
  • Patent number: 11292849
    Abstract: This disclosure relates to anti-TNFRSF9 (tumor necrosis factor receptor superfamily member 9) antibodies, antigen-binding fragments, and the uses thereof.
    Type: Grant
    Filed: March 12, 2021
    Date of Patent: April 5, 2022
    Assignee: Eucure (Beijing) Biopharma Co., Ltd.
    Inventors: Yi Yang, Jingshu Xie, Chunyan Dong, Fang Yang, Chengyuan Lu, Yuelei Shen, Jian Ni, Yanan Guo, Yunyun Chen
  • Publication number: 20220092262
    Abstract: A processor may receive a text segment. The processor may analyze the text segment at a plurality of granularity levels wherein each of the plurality of granularity levels has a comparative selection value for identifying one or more objects of interest within the text segment. The processor may select an optimized granularity level with an optimum comparative selection value. The processor may identify the one or more objects of interest within the text segment. The processor may display the one or more objects of interest to a user.
    Type: Application
    Filed: September 18, 2020
    Publication date: March 24, 2022
    Inventors: Jian Ni, Radu Florian, Salim Roukos, Vittorio Castelli
  • Publication number: 20220073621
    Abstract: The present application provides an anti-PD-L1 antibody, an antigen-binding fragment thereof, and use thereof. The present application also provides a multispecific antibody such as a bispecific antibody, a conjugate, and a composition comprising the anti-PD-L1 antibody or the antigen-binding fragment thereof, and use thereof in treatment of diseases such as cancer.
    Type: Application
    Filed: August 20, 2020
    Publication date: March 10, 2022
    Inventors: Yi Yang, Jingshu Xie, Chunyan Dong, Fang Yang, Chengyuan Lu, Yuelei Shen, Jian Ni, Ya'nan Guo, Yunyun Chen
  • Patent number: 11240995
    Abstract: The present disclosure relates to the genetically modified non-human animals that express a human or chimeric (e.g., humanized) T-cell immunoglobulin and mucin-domain containing-3 (TIM-3), and methods of use thereof.
    Type: Grant
    Filed: May 10, 2019
    Date of Patent: February 8, 2022
    Assignee: Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
    Inventors: Yuelei Shen, Jian Ni, Yanan Guo, Rui Huang, Meiling Zhang, Lei Zhao, Yang Bai
  • Publication number: 20210403588
    Abstract: This disclosure relates to anti-CD40 (TNF Receptor Superfamily Member 5) antibodies, antigen-binding fragments, and the uses thereof.
    Type: Application
    Filed: September 8, 2021
    Publication date: December 30, 2021
    Inventors: Yi Yang, Chunyan Dong, Fang Yang, Chengyuan Lu, Yuelei Shen, Jian Ni, Yanan Guo, Yunyun Chen, Jingshu Xie
  • Publication number: 20210403570
    Abstract: This disclosure relates to anti-PD-1 (Programmed Cell Death Protein 1) antibodies, antigen-binding fragments, and the uses thereof.
    Type: Application
    Filed: September 17, 2021
    Publication date: December 30, 2021
    Inventors: Yi Yang, Jingshu Xie, Chunyan Dong, Fang Yang, Chengyuan Lu, Xiaodong Cheng, Yuelei Shen, Jian Ni, Yanan Guo, Yunyun Chen
  • Patent number: 11155625
    Abstract: This disclosure relates to anti-PD-1 (Programmed Cell Death Protein 1) antibodies, antigen-binding fragments, and the uses thereof.
    Type: Grant
    Filed: July 2, 2020
    Date of Patent: October 26, 2021
    Assignee: Eucure (Beijing) Biopharma Co., Ltd
    Inventors: Yi Yang, Jingshu Xie, Chunyan Dong, Fang Yang, Chengyuan Lu, Xiaodong Cheng, Yuelei Shen, Jian Ni, Yanan Guo, Yunyun Chen
  • Patent number: 11142582
    Abstract: This disclosure relates to anti-CD40 (TNF Receptor Superfamily Member 5) antibodies, antigen-binding fragments, and the uses thereof.
    Type: Grant
    Filed: January 14, 2021
    Date of Patent: October 12, 2021
    Assignee: Eucure (Beijing) Biopharma Co., Ltd
    Inventors: Yi Yang, Chunyan Dong, Fang Yang, Chengyuan Lu, Yuelei Shen, Jian Ni, Yanan Guo, Yunyun Chen, Jingshu Xie
  • Publication number: 20210284735
    Abstract: This disclosure relates to anti-PD-1 (Programmed Cell Death Protein 1) antibodies, antigen-binding fragments, and the uses thereof.
    Type: Application
    Filed: May 19, 2021
    Publication date: September 16, 2021
    Inventors: Yi Yang, Chunyan Dong, Fang Yang, Chengyuan Lu, Yuelei Shen, Jian Ni, Yanan Guo, Yunyun Chen, Jingshu Xie
  • Publication number: 20210269525
    Abstract: This disclosure relates to anti-CD3e (T-cell surface glycoprotein CD3 epsilon chain) antibodies, antigen-binding fragments, and the uses thereof.
    Type: Application
    Filed: June 19, 2019
    Publication date: September 2, 2021
    Inventors: Yi Yang, Yunyun Chen, Jingshu Xie, Chunyan Dong, Fang Yang, Chengyuan Lu, Xiaodong Cheng, Yuelei Shen, Jian Ni, Yanan Guo
  • Patent number: 11062726
    Abstract: A method of providing real-time speech analysis to a user includes capturing a speech input, performing a real-time recognition of the speech input including converting the speech input to a text, analyzing the recognized speech input to identify an error in a voice of the user, the analyzing including comparing a voice of a correct text generated by an automated speech generation system with the captured speed input, and processing the text to extract a context dialog prompt.
    Type: Grant
    Filed: January 27, 2020
    Date of Patent: July 13, 2021
    Assignee: INTERNATIONAL BUSINESS MACHINES CORPORATION
    Inventors: Sasha P. Caskey, Jian Ni, Andrzej Sakrajda, Hui Wan, Cheng Wu
  • Publication number: 20210206866
    Abstract: This disclosure relates to anti-OX40 (TNF Receptor Superfamily Member 4, or TNFRSF4) antibodies, antigen-binding fragments, and the uses thereof.
    Type: Application
    Filed: January 5, 2021
    Publication date: July 8, 2021
    Inventors: Yi Yang, Yanan Guo, Yunyun Chen, Jingshu Xie, Chunyan Dong, Fang Yang, Chengyuan Lu, Xiaodong Cheng, Yuelei Shen, Jian Ni